Docosahexaenoic acid synthesis from n-3 fatty acid precursors in rat hippocampal neurons

Journal of Neurochemistry

Volumn 105, Issue 4, 2008, Pages 1525-1535

  Kaduce, Terry L ^a   Chen, Yucui ^a,b   Hell, Johannes W ^a   Spector, Arthur A ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

linolenic acid; Arachidonic acid; Brain; Eicosapentaenoic acid; Linoleic acid; Phospholipids

Indexed keywords

ARACHIDONIC ACID; CARBON 14; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; LINOLEIC ACID; OMEGA 3 FATTY ACID; PHOSPHATIDYLETHANOLAMINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CELL CULTURE; HIPPOCAMPUS; ISOTOPE LABELING; NONHUMAN; PRIORITY JOURNAL; RAT; SYNTHESIS;

ANIMALS; CELLS, CULTURED; DOCOSAHEXAENOIC ACIDS; FATTY ACIDS, OMEGA-3; HIPPOCAMPUS; NEURONS; RATS; RATS, SPRAGUE-DAWLEY;

RATTUS;

EID: 42549151044     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2008.05274.x     Document Type: Article

References (65)

1. Abedin L., Lien E. L., Vingrys A. J. Sinclair A. J. (1999) The effects of dietary α-linolenic acid compared with docosahexaenoic acid on brain, liver and heart in the guinea pig. Lipids 34, 475 482.
2. Ahmad A., Murthy M., Greiner R. S., Moriguchi T. Salem N. Jr. (2002) A decrease in cell size accompanies a loss of docosahexaenoate in the rat hippocampus. Nutr. Neurosci. 5, 103 113.
3. Akbar M., Calderon F., Wen Z. Kim H.-Y. (2005) Docosahexaenoic acid: a positive modulator of Akt signaling in neuronal survival. Proc. Natl Acad. Sci. USA 102, 10858 10863.
4. Arai T., Wakabayashi S., Channing M. A., Dunn B. B., Der M. G., Bell J. M., Herscovitch P., Eckelman W. C., Rapoport S. I. Chang M. C. (1995) Incorporation of [1-carbon-11]palmitate in monkey brain using PET. J. Nuc. Med. 36, 2261 2267.
5. Bazan N. G. (2007) Omega-3 fatty acids, pro-inflammatory signaling and neuroprotection. Curr. Opin. Clin. Nutr. Metab. Care. 10, 136 141.
6. Bourre J. M., Piciotti M. Dumont O. (1990) Delta 6 desaturase in brain and liver during development and aging. Lipids 25, 354 365.
7. Brenna J. T. (2002) Efficiency of conversion of α-linolenic acid to long chain n-3 fatty acids in man. Curr. Opin. Clin. Nutr. Metab. Care. 5, 127 132.
8. Brewer G. J., Torricelli J. R., Evege E. K. Price P. J. (1993) Optimized survival of hippocampal neurons in B27-supplemented Neurobasal, a new serum-free medium combination. J. Neurosci. Res. 35, 567 576.
9. Bruno M. J., Koeppe R. E. Andersen O. S. (2007) Docosahexaenoic acid alters bilayer elastic properties. Proc. Natl Acad. Sci. USA 104, 9638 9643.
10. Burdge G. C. (2006) Metabolism of α-linolenic acid in humans. Prostaglandins Leukot. Essent. Fatty Acids 75, 161 168.
11. Calderon F. Kim H.-Y. (2004) Docosahexaenoic acid promotes neurite growth in hippocampal neurons. J. Neurochem. 90, 979 988.
12. Contreras M. A., Chang M. C., Kirkby D., Bell J. M. Rapoport S. I. (1999) Reduced palmitate turnover in brain phospholipids of pentobarbital-anesthetized rats. Neurochem. Res. 24, 833 841.
13. Cunnane S. C., Menard C. R., Likhodii S. S., Brenna J. T. Crawford M. A. (1999) Carbon recycling into de novo lipogenesis is a major pathway in neonatal metabolism of linoleate and α-linolenate. Prostaglandins Leukot. Essent. Fatty Acids 60, 387 392.
14. DeMar J. C., Ma K., Chang L., Bell J. M. Rapoport S. I. (2005) α-Linolenic acid does not contribute appreciably to docosahexaenoic acid within brain phospholipids of adult rats fed a diet enriched in docosahexaenoic acid. J. Neurochem. 94, 1063 1076.
15. DeMar J. C., Lee H. J., Ma K., Chang L., Bell J. M., Rapoport S. I. Bazinet R. P. (2006) Brain elongation of linoleic acid is a negligible source of the arachidonate in brain phospholipids of adult rats. Biochim. Biophys. Acta 1761, 1050 1059.
16. Dhopeshwarkar G. A. Subramanian C. (1976) Biosynthesis of polyunsaturated fatty acids in the developing brain: I. Metabolic transformations of intracranially administered 1-14C linolenic acid. Lipids 11, 67 71.
17. Diau G. Y., Hsieh A. T., Sarkadi-Nagy E. A., Wijendran V., Nathanielsz P. W. Brenna J. T. (2005) The influence of long chain polyunsaturated supplementation on docosahexaenoic acid and arachidonic acid in baboon neonate central nervous system. BMC Med. 3, 11.
18. Edmond J. (2001) Essential polyunsaturated fatty acids and the barrier to the brain. The components of a model for transport. J. Mol. Neurosci. 16, 181 193.
19. Edmond J., Higa T. A., Korsak R. A., Bergner E. A. Lee W.-N. P. (1998) Fatty acid transport and utilization for the developing brain. J. Neurochem. 70, 1227 1234.
20. Eldho N. V., Feller S. E., Tristram-Nagle S., Polozov I. V. Gawrisch K. (2003) Polyunsaturated docosahexaenoic vs docosapentaenoic acid - differences in lipid matrix properties from the loss of one double bond. J. Am. Chem. Soc. 125, 6409 6421.
21. Fam S. S., Murphy L. J., Terry E. S. et al. (2002) Formation of highly reactive A-ring and J-ring isoprostane-like compounds (A4/J4-neuroprostanes) in vivo from docosahexaenoic acid. J. Biol. Chem. 277, 36076 36084.
22. Florent S., Malaplate-Armand C., Youssef I. et al. (2006) Docosahexaenoic acid prevents neuronal apoptosis induced by soluble amyloid-beta oligomers. J. Neurochem. 96, 385 395.
23. Gawrisch K., Eldho N. V. Holte L. L. (2003) The structure of DHA in phospholipid membranes. Lipids 38, 445 452.
24. Goldstein J. T., Dobrzyn A., Clagett-Dame M., Pike J. W. DeLuca H. F. (2003) Isolation and characterization of unsaturated fatty acids as natural ligands for the retinoid-X receptor. Arch. Biochem. Biophys. 420, 185 193.
25. Grange E., Deutsch J., Smith Q. R., Chang M., Rapoport S. I. Purdon A. D. (1995) Specific activity of brain palmitoyl-CoA pool provides rates of incorporation of palmitate in brain phospholipids in awake rats. J. Neurochem. 65, 2290 2298.
26. Green P. Yavin E. (1993) Elongation, desaturation, and esterification of essential fatty acids by fetal rat brain in vivo. J. Lipid Res. 34, 2099 2107.
27. Igarashi M., DeMar J. C., Ma K., Chang L., Bell J. M. Rapoport S. I. (2007) Upregulated liver conversion of α-linolenic acid to docosahexaenoic acid in rats on a 15 week n-3 PUFA-deficient diet. J. Lipid Res. 48, 152 164.
28. Jelks K. B., Wylie R., Floyd C. L., McAllister A. K. Wise P. (2007) Estradiol targets synaptic proteins to induce glutaminergic synapse formation in cultured hippocampal neurons: critical role of estrogen receptor-α. J. Neurosci. 27, 6903 6913.
29. Kan I., Melamed E., Offen D. Green P. (2007) Docosahexaenoic acid and arachidonic acid are fundamental supplements for the induction of neuronal differentiation. J. Lipid Res. 48, 513 517.
30. Kawakita E., Hashimoto M. Shido O. (2006) Docosahexaenoic acid promotes neurogenesis in vitro and in vivo. Neuroscience 139, 991 997.
31. Kelly B. L. Ferreira A. (2007) β-Amyloid disrupted synaptic vesicle endocytosis in cultured hippocampal neurons. Neuroscience 147, 60 70.
32. Kim H.-Y., Akbar M., Lau A. Edsall L. (2000) Inhibition of neuronal apoptosis by docosahexaenoic acid (22:6n-3). Role of phosphatidylserine in antiapoptotic effect. J. Biol. Chem. 275, 35215 35223.
33. Krueger S. R., Kolar A. Fitzsimonds R. M. (2003) The presynaptic release apparatus is functional in the absence of dendritic contact and highly mobile within isolated axons. Neuron 40, 945 957.
34. Lauritzen L., Hansen H. S., Jørgensen M. H. Michaelsen K. F. (2001) The essentiality of long chain n-3 fatty acids in relation to development and function of the brain and retina. Prog. Lipid Res. 40, 1 94.
35. Lefkowitz W., Lim S.-Y., Lin Y. Salem N. Jr. (2005) Where does the developing brain obtain its docosahexaenoic acid? Relative contributions of dietary α-linolenic acid, docosahexaenoic acid, and body stores in the developing rat Pediatr. Res. 57, 157 165.
36. Lim I. A., Merrill M. A., Chen Y. Hell J. W. (2003) Disruption of the NMDA receptor-PSD-95 interaction in hippocampal neurons with no obvious physiological short-term effects. Neuropharmacology 45, 738 754.
37. Lim S. Y., Hoshiba J., Moriguchi T. Salem N. (2005a) N-3 fatty acid deficiency induced by a modified artificial rearing method leads to poorer performance in spatial learning tasks. Pediatr. Res. 58, 741 748.
38. Lim S. Y., Hoshiba J. Salem N. (2005b) An extraordinary degree of structural specificity is required in neural phospholipids for optimal brain function: n-6 docosapentaenoic acid substitution for docosahexaenoic acid leads to a loss in spatial task performance. J. Neurochem. 95, 848 857.
39. Litman B. J., Niu S. L., Polozova A. Mitchell D. C. (2001) Role of docosahexaenoic acid containing phospholipids in modulating G protein-coupled signaling pathways. J. Mol. Neurosci. 16, 153 158.
40. Lukiw W. J., Cui J. G., Marcheselli V. L., Bodker M., Botkaejr A., Gotlinger K., Serhan C. N. Bazan N. G. (2005) A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease. J. Clin. Invest. 115, 2774 2783.
41. Mata de Urquiza A., Liu S., Sjöberg M., Zetterström R. H., Griffiths W., Sjövall J. Perlmann T. (2000) Docosahexaenoic acid, a ligand for the retinoid X receptor. Science 290, 2140 2144.
42. Moore S. A., Yoder E. Spector A. A. (1990) Role of the blood-brain barrier in the formation of long-chain ω-3 and ω-6 fatty acids from essential fatty acid precursors. J. Neurochem. 55, 391 402.
43. Moore S. A., Yoder E., Murphy S., Dutton G. R. Spector A. A. (1991) Astrocytes, not neurons, produce docosahexaenoic acid (22:6ω-3) and arachidonic acid (20:4ω-6). J. Neurochem. 56, 518 524.
44. Noelle Marbois B., Ajie H. O., Korsak R. A., Sensharma D. K. Edmond J. (1992) The origin of palmitic acid in brain of the developing rat. Lipids, 27, 587 592.
45. Ohno-Shosaku T., Hashimotodani Y., Ano M., Takeda S., Tsubokawa H. Kano M. (2007) Endocannabinoid signaling triggered by NMDA receptor-mediated calcium entry into hippocampal neurons. J. Physiol. 584 (2 407 418.
46. Raffick A., Bowen R. Clandinin M. T. (2005) Maternal dietary 22: 6n-3 is more effective than 18: 3n-3 in increasing the 22: 6n-3 content in phospholipids of glial cells from neonatal brain. Brit. J. Nutr. 93, 601 611.
47. Rapoport S. I. (2001a) In vivo fatty acid incorporation into brain phospholipids in relation to plasma availability, signal transduction, and membrane remodeling. J. Mol. Neurosci. 16, 243 261.
48. Rapoport S. I., Chang M. C. J. Spector A. A. (2001b) Delivery and turnover of plasma-derived essential PUFAs in mammalian brain. J. Lipid Res. 42, 678 685.
49. Richardson U. I. Wurtman R. J. (2007) Polyunsaturated fatty acids stimulate phosphatidylcholine synthesis in PC12 cells. Biochim. Biophys. Acta 1771, 558 563.
50. Roberts II. L. J., Montine T. J., Markesbery W. R., Tapper A. R., Hardy P., Chemtob S., Dettbarn W. D. Morrow J. D. (1998) Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid. J. Biol. Chem. 273, 13605 13612.
51. Salem N. Jr., Wegher B., Mwna P. Uauy R. (1996) Arachidonic and docosahexaenoic acids are biosynthesized from their 18-carbon precursors in human infants. Proc. Natl Acad. Sci. USA 93, 49 54.
52. Salem N. Jr., Litman B., Kim H.-Y. Gawrisch K. (2001) Mechanism of action of docosahexaenoic acid in the nervous system. Lipids 36, 945 959.
53. Scott B. L. Bazan N. G. (1989) Membrane docosahexaenoate is supplied to the developing brain and retina by the liver. Proc. Natl Acad. Sci. USA 86, 2903 2907.
54. Serhan C. N., Gotlinger K., Hong S., Lu Y., Siegelman J., Baer T., Yang R., Colgan S. P. Petasis N. A. (2006) Anti-inflammatory actions of neuroprotectin D1/protectin D1 and its natural stereoisomers: assignments of dihydroxy-containing docosatrienes. J. Immunol. 176, 1848 1859.
55. Spector A. A. (1999) Essentiality of fatty acids. Lipids 34 (Suppl. S1 S3.
56. Spector A. A. Moore S. A. (1993) Role of cerebrovascular endothelium and astrocytes in supplying docosahexaenoic acid to the brain, in Essential Fatty Acids and Eicosanoids (Sinclair A. Gibson R., eds pp. 100 103. American Oil Chemist Society, Champaign, IL.
57. Sprecher H., Luthria D. L., Mohammed B. S. Baykousheva S. P. (1995) Reevaluation of the pathways for the biosynthesis of polyunsaturated fatty acids. J. Lipid Res. 36, 2471 2477.
58. Stoll L. L. Spector A. A. (1984) Changes in serum influence the fatty acid composition of established cell lines. In Vitro 20, 732 738.
59. Su H. M., Huang M. C., Saad N. M., Nathanielsz P. W. Brenna J. T. (2000) Fetal baboons convert 18:3n-3 to 22:6n-3in vivo: a stable isotope tracer study. J. Lipid Res. 42, 581 586.
60. Vartak S., McCaw R., Davis C. S., Robbins M. E. C. Spector A. A. (1998) γ-Linolenic acid (GLA) is cytotoxic to 36B10 malignant rat astrocytoma cells but not to 'normal' rat astrocytes. Brit. J. Cancer. 77, 1612 1620.
61. Vereyken E. J., Bajova H., Chow S., deGraan P. N. Gruol D. L. (2007) Chronic interleukin-6 alters the level of synaptic proteins in hippocampus in culture and in vivo. Eur. J. Neurosci. 25, 3605 3616.
62. Williard D. E., Harmon S. D., Kaduce T. L., Preuss M., Moore S. A., Robbins M. E. C. Spector A. A. (2001a) Docosahexaenoic acid synthesis from n-3 polyunsaturated fatty acids in differentiated rat brain astrocytes. J. Lipid Res. 42, 1368 1376.
63. 6-desaturase deficiency in human skin fibroblasts. J. Lipid Res. 42, 501 508.
64. Woods J., Ward G. Salem N. (1996) Is docosahexaenoic acid necessary in infant formula? Evaluation of high linolenate diets in the neonatal rat Pediatr. Res. 40, 687 694.
65. Yavin E. (2006) Versatile roles of docosahexaenoic acid in the prenatal brain: from pro- and anti-oxidant features to regulation of gene expression. Prostaglandins Leukot. Essent. Fatty Acids 75, 203 211.